Flasshove M, Leonard JP, Bardenheuer W, Moore MAS. Increased resistance and selection in paclitaxel for peripheral
blood progenitor cells following transduction with the MDR1 gene. Tumor Diagnostik & Therapie 2000; 21:51-58.
Kikuchi T, Moore MAS, Crystal RG. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against
pre-existing murine tumors. Blood 2000, 96; 91-99.
Fushimi T, Kojima A, Moore MAS, Crystal RG. Macrophage inflammatory protein 3? attracts dendritic cells to
established murine tumors and suppresses tumor growth. J Clin Invest 2000, 105:1383-93.
Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, MAS Moore,
Rafii S. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest. 2000,
106;511-21.
Kikuchi T, Worgall S, Singh R, Moore MAS, Crystal RG. Dendritic cells genetically modified to express CD40 ligand and
pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4-T cells. Nature Medicine 2000,
6;1154-59.
Kikuchi T, Miyazawa N, Moore MAS, Crystal RG. Tumor regression induced by intratumor administration of adenovirus
vector expressing CD40 ligand and naïve dendritic cells. Cancer Res. 2000, 60:6391-5.
Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S.
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of
vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005-1014.
Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S. Inhibition of both
paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of
xenotransplanted human leukemias. Proc Natl Acad Sci USA, 2001, 98: 10857-62.
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z,
Hackett NR, Crystal RG, Moore MAS, Hajjar KA, Manova K, Benezra R, Rafii S. Impaired recruitment of bone-marrow-
derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med 2001, 7;
1194-1201.
Lane WJ, Hattori K, Dias S, Peerschke EI, Moore MA, Blanset DL, Lang PC, Petrone M, Rafii S. Anagrelide metabolite
induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation. Exp
Hematol. 2001, Dec; 29:1417-24.
Takebe N, Li-Cheng X, MacKenzie KL, Bertino JR, Moore MAS. Methotrexate selection of long term culture initiating
cells following transduction of CD34+ cells with a retrovirus containing a mutated human of dihydrofolate reductase
gene. Cancer Gene Therapy 2002;9:308-320.
Wang E, O'Connor O, She Y, Zelenetz A, Sirotnak FM, Moore MAS. Activity of a novel anti-folate (PDX, 10-propargyl
-10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene
expression. Leukemia & Lymphoma 2003, 44:1027-1035.
Moldenhauer A, Nociari MM, Dias S, Lalezari P, Moore MAS. Optimized culture conditions for the generation of
dendritic cells from peripheral blood monocytes. Vox Sanguinis 2003, 84:228-236.
Sommer G, Agosti V, Ehlers I, Rossi F, Corbacioglu S, Farkas J, Moore M, Manova K, Antonescu CR, Besmer P.
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc
National Acad Science 2003. 100:6706-6711.
Wang E, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MAS. Targeting autocrine and paracrine VEGF receptor
pathways inhibits human lymphoma xenographs in vivo. Blood. 2004. 104:2893-902.
Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Methotrexate and cytarabine inhibit
progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase
fusion gene. Mol Ther. 2004 Sep;10(3):574-84.
Gaul C, Njardarson JT, Shan D, Dorn DC, Wu KD, Tong WP, Huang XY, Moore MA, Danishefsky SJ. The migrastatin
family: discovery of potent cell migration inhibitors by chemical synthesis. J Am Chem Soc. 2004,126:11326-37.
|
